Predicting Acute Myocardial Infarction with a Single Blood Draw [Proteomics and Protein Markers]

CONCLUSIONS:
Serial sampling does not seem necessary for predicting AMI and concurrent decision-making in about 10% of patients, as it only marginally increases the PPV for AMI and not in a statistically or clinically significant way.

ClinicalTrials.gov Identifier:
NCT00470587.

Source: Clinical Chemistry - February 28, 2019 Category: Chemistry Authors: Boeddinghaus, J., Nestelberger, T., Badertscher, P., Twerenbold, R., Fitze, B., Wussler, D., Strebel, I., Rubini Gimenez, M., Wildi, K., Puelacher, C., du Fay de Lavallaz, J., Oehen, L., Walter, J., Miro, O., Martin-Sanchez, F. J., Morawiec, B., Potlukova Tags: Proteomics and Protein Markers Source Type: research